Molsidomine: Difference between revisions
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
| UNII = D46583G77X | | UNII = D46583G77X | ||
| verifiedrevid = 446670426 | | verifiedrevid = 446670426 | ||
|ImageFile=Molsidomine. | |ImageFile=Molsidomine.png | ||
|ImageSize=200px | |ImageSize=200px | ||
|IUPACName=1-Ethoxy-''N''-(3-morpholino-5-oxadiazol-3-iumyl)methanimidate | |IUPACName=1-Ethoxy-''N''-(3-morpholino-5-oxadiazol-3-iumyl)methanimidate |
Latest revision as of 21:32, 24 July 2014
Names | |
---|---|
IUPAC name
1-Ethoxy-N-(3-morpholino-5-oxadiazol-3-iumyl)methanimidate
| |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider | |
ECHA InfoCard | Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). |
KEGG | |
PubChem CID
|
|
| |
| |
Properties | |
C9H14N4O4 | |
Molar mass | 242.23 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
verify (what is ?) | |
Infobox references | |
WikiDoc Resources for Molsidomine |
Articles |
---|
Most recent articles on Molsidomine Most cited articles on Molsidomine |
Media |
Powerpoint slides on Molsidomine |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Molsidomine at Clinical Trials.gov Clinical Trials on Molsidomine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Molsidomine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Molsidomine Discussion groups on Molsidomine Patient Handouts on Molsidomine Directions to Hospitals Treating Molsidomine Risk calculators and risk factors for Molsidomine
|
Healthcare Provider Resources |
Causes & Risk Factors for Molsidomine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Molsidomine is an orally active, long acting vasodilating drug. Molsidomine is metabolized in the liver to the active metabolite SIN-1. SIN-1 is an unstable compound that releases nitric oxide upon decay as the actual vasodilating compound.
Chemistry
Molsidomine as well as SIN-1 are sydnone imines, a class of mesoionic heterocyclic aromatic chemical compounds.
References
See Also
- Pages with script errors
- Pages using duplicate arguments in template calls
- Articles without UNII source
- Chemical articles with unknown parameter in Chembox
- Articles with changed EBI identifier
- ECHA InfoCard ID from Wikidata
- Articles containing unverified chemical infoboxes
- Chembox image size set
- Cardiovascular Drugs
- Drug
- Vasodilators